Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction
NCT00661115Phase 3Completed
- Sponsor
- Bayer
- Start
- May 2003
- Primary completion
- Feb 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in erectile dysfunction (ED) comparing Levitra (Vardenafil) with Placebo (2 arms). Primary endpoint: Erectile function (EF) domain score of the International Index of Erectile Function (IIEF) at 12 weeks. Started May 2003; status: completed.
02
Drugs
vardenafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT00661115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00661115.